Related Experiment Videos
Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins
Lutz-W Weber1, Meinrad Boll, Andreas Stampfl
1Institute of Toxicology, GSF-National Research Center for Environment and Health, Munich, D-85758 Neuherberg, Germany. stampfl@gsf.de
World Journal of Gastroenterology
|October 1, 2004
Summary
Sterol regulatory element binding proteins (SREBPs) control cholesterol synthesis by activating genes. Their activation in the Golgi, regulated by SCAP and sterol levels, releases nuclear SREBP to regulate gene expression, offering therapeutic potential.
Area of Science:
- Molecular biology
- Cellular biology
- Biochemistry
Background:
- Hepatocytes maintain cholesterol homeostasis through complex molecular mechanisms.
- Sterol regulatory element binding proteins (SREBPs) are key transcription factors involved in this process.
- SREBPs belong to the basic helix-loop-helix-leucine zipper (bHLH-Zip) family and regulate genes for cholesterol and lipid synthesis.
Purpose of the Study:
- To elucidate the molecular mechanism of SREBP-mediated cholesterol homeostasis in hepatocytes.
- To understand the role of SCAP in regulating SREBP activity based on cellular sterol levels.
- To explore the potential of targeting the SREBP/SCAP system for managing cholesterol-related diseases.
Main Methods:
- The study describes the known pathway of SREBP synthesis, complexation with SCAP in the ER, and transport to the Golgi.
- It details the proteolytic cleavage of SREBP in the Golgi to release the active nuclear form (nSREBP).
- The mechanism of nSREBP translocation to the nucleus and binding to sterol response elements (SREs) is outlined.
Main Results:
- SREBPs activate at least 30 genes crucial for cholesterol and lipid synthesis.
- SCAP's sterol-sensing domain controls SREBP localization, confining it to the ER at high sterol levels and escorting it for activation at low levels.
- Three SREBP forms (SREBP-1a, -1c, and -2) are identified, with -1a and -1c being splice variants and -2 encoded by a separate gene.
Conclusions:
- SREBPs, in conjunction with SCAP, play a central role in regulating cholesterol synthesis.
- While SREBPs alone can control cholesterol synthesis, lipid metabolism requires additional factors like hormones and cytokines.
- The SREBP/SCAP pathway presents a promising target for therapeutic interventions in cholesterol-related diseases.